Navigation Links
Johnson & Johnson Reports 2008 Third-Quarter Results:
Date:10/14/2008

leptic and a treatment for the prevention of migraine headaches; and RISPERDAL CONSTA, an antipsychotic medication. Sales results of RISPERDAL were negatively impacted by generic competition.

During the quarter, the European Commission granted marketing authorization for INTELENCE, a next generation non-nucleoside reverse transcriptase inhibitor; DORIBAX, an antibiotic used as a treatment for complicated urinary tract infections, complicated intra-abdominal infections, and nosocomial pneumonia including ventilator-associated pneumonia; and for VELCADE, in combination with melphalan and prednisone, for the treatment of patients with previously untreated multiple myeloma. In addition, the Company submitted a New Drug Application to the U.S. Food and Drug Administration (FDA) for rivaroxaban, an investigational, oral, once daily anticoagulant for the prevention of deep vein thrombosis and pulmonary embolism in patients undergoing hip or knee replacement surgery. The Company also submitted a supplemental new drug application to the FDA for the combination of DOXIL and Taxotere(R) for the treatment of women with advanced breast cancer who have received prior anthracycline treatment. In July, the FDA granted pediatric exclusivity for TOPAMAX extending the marketing exclusivity through March 2009.

About Johnson & Johnson

Caring for the world, one person at a time...inspires and unites the people of Johnson & Johnson. We embrace research and science - bringing innovative ideas, products and services to advance the health and well-being of people. Our 119,400 employees at more than 250 Johnson & Johnson companies work with partners in health care to touch the lives of over a billion people every day, throughout the world.

* Net earnings and diluted earnings per share excluding special items, such as after-tax in-process research and development charges and restructuring charges, are non-GAAP financial measures and should not be considered replacem
'/>"/>

SOURCE Johnson & Johnson
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

Related medicine news :

1. Johnson & Johnson to Participate in Bear Stearns 20th Annual Healthcare Conference
2. Draxis Health selected by Johnson and Johnson Consumer Companies, Inc. for major contract manufacturing relationship
3. Johnson & Johnson Campaign for Nursings Future Joins With AACN to Offer New Minority Nurse Faculty Scholars Program
4. Trust for Americas Health Receives $7.6 Million Grant from the Robert Wood Johnson Foundation to Advance the Quality and Impact of the Public Health System
5. Deane F. Johnson Center for Neurotherapeutics to Launch First Mobile Medical Unit on October 4th
6. Johnson & Johnson Tops Annual Pharmaceutical Company Rankings in a New Report From Industry-Leading Publication Scrip
7. Independence Technology, A Johnson & Johnson Company, Renews Its Contract With Creative Technology Services
8. Johnson & Johnson Launches Global Diabetes Institute to Provide State-of-The- Art Education, Training to Health Professionals
9. Robert Wood Johnson Foundation Announces $15.6 Million Grant to Apply Power of the Archimedes Model to Critical Health Care Decisions
10. UAN Mourns Passing of President Cheryl L. Johnson, RN
11. Johnson & Johnson Pharmaceutical Research & Development Submits New Drug Application for Paliperidone Palmitate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... EverStryke , the permanent match currently offered by ... a free book and class all about survival education and ... investigative review. , “Joe Marshall of SurvivalLife.com is one ... niche, and this product is an excellent way to get ... that Joe offers on his website to help people be ...
(Date:9/30/2014)... 30, 2014 Elevate , the latest ... better in and out of the gym by providing natural ... the attention of Shane Michaels, prompting an investigative review. ... the reason most people simply just don’t have the ability ... focused at work, getting the motivation to finish a project, ...
(Date:9/30/2014)... CA (PRWEB) September 30, 2014 ... providers in Turkey has gone up more than 79 ... The medical tourism company also reported total revenue tripled ... 2012. , The company’s professional strategy has allowed them ... — ultimately designed for patient comfort and privacy — ...
(Date:9/30/2014)... Plains, NY (PRWEB) September 30, 2014 ... recently hosted its annual “In Celebration” gala, honoring ... the nonprofit’s mission of striving to provide extraordinary ... and families facing a serious or life-limiting illness. ... Country Club in Rye, NY and recognized William ...
(Date:9/30/2014)... September 30, 2014 Regenerative Medicine Solutions ... new clinics in Nashville, Tennessee. RMS welcomes the launch ... and the expansion of a new treatment center for ... the Sleep Apnea Institute to Nashville, the hope is ... sleep apnea: both diagnosed and undiagnosed. With Nashville being ...
Breaking Medicine News(10 mins):Health News:EverStryke: Review Exposes Joe Marshall’s Permanent Match Survival Product 2Health News:Elevate: Review Exposes Blue Star Nutraceutical’s Latest Supplement for Ultimate Brain Function, Focus, and Energy 2Health News:VisitandCare.com Announces Record Demand for Plastic Surgery in Turkey 2Health News:VisitandCare.com Announces Record Demand for Plastic Surgery in Turkey 3Health News:VisitandCare.com Announces Record Demand for Plastic Surgery in Turkey 4Health News:Hospice & Palliative Care of Westchester Honors Outstanding Individuals at Annual ‘In Celebration’ Gala 2Health News:Regenerative Medicine Solutions Expanding 2
... Oct. 2 APWU Health Plan is proud to announce ... High Option sees a four percent increase in it,s rate, ... increase. APWU Health Plan is offering the same comprehensive ... adding new benefits and enhancing old ones. We will ...
... in study , FRIDAY, Oct. 2 (HealthDay News) -- Children ... likely to be convicted of violent crimes as adults, a ... looked at data on 17,415 children born in a single ... from the British Cohort Study, included detailed health and lifestyle ...
... of dentists and reaffirms patient advocacy , HONOLULU, ... of its 150th birthday will culminate with tonight,s spectacular program, ... "The ADA,s 150th anniversary is a very significant achievement in ... President John S. Findley, D.D.S. "It also is a ...
... Oct. 2 Beginning October 1st, The Peninsula Chicago will ... Awareness Month and several cancer research and education organizations. , ... breast cancer in some way and this is why we ... Maria Zec, general manager of The Peninsula Chicago. "In addition ...
... study patients , FRIDAY, Oct. 2 (HealthDay News) -- ... for surgery in ulcerative colitis patients by almost half, ... inflammation of the colon and often leads to surgical ... 728 patients who received either an inactive placebo or ...
... linked to reduced risk, study finds , FRIDAY, Oct. ... can reduce the risk of falls in seniors, say researchers ... participants aged 65 and older. , The analysis revealed that ... vitamin D per day (vitamin D2 or D3) reduces falls ...
Cached Medicine News:Health News:Daily Candy in Childhood Linked to Violence in Adulthood 2Health News:Daily Candy in Childhood Linked to Violence in Adulthood 3Health News:ADA Culminates Yearlong 150th Anniversary Observance at Its 150th Annual Session 2Health News:ADA Culminates Yearlong 150th Anniversary Observance at Its 150th Annual Session 3Health News:The Peninsula Chicago Gives Back During Breast Cancer Awareness Month 2Health News:Daily Dose of Vitamin D Helps Prevent Falls in Seniors 2
(Date:9/30/2014)... 2014 According to ... by Product [Enzymes (Glycosyltransferase, Neuraminidase, Glycosidase), Instruments ... Application (Immunology, Oncology) & by End User ... MarketsandMarkets, provides a detailed overview of the ... trends, and strategies impacting the global glycomics ...
(Date:9/30/2014)... LOS ANGELES , Sept. 30, 2014   ... apnea shopping destination , today announced that it now ... ResMed . AirSense CPAPs are the first sleep apnea ... makes it simple and easy to track and share ... the overall effectiveness of their CPAP therapy.  In addition, ...
(Date:9/30/2014)... , Sept. 30, 2014 The Chinese ... ageing population and rise in the incidence of lifestyle ... wounds and in affordability of better quality of wound ... care market. Universal coverage of public health insurance schemes ... further stimulate demand. Based on the findings of primary ...
Breaking Medicine Technology:Glycobiology / Glycomics Market Worth $928.11 Million by 2019 2Glycobiology / Glycomics Market Worth $928.11 Million by 2019 3Glycobiology / Glycomics Market Worth $928.11 Million by 2019 4Easy Breathe Now Offers World's First "Smart" CPAP Device to Treat Sleep Apnea 2Easy Breathe Now Offers World's First "Smart" CPAP Device to Treat Sleep Apnea 3Easy Breathe Now Offers World's First "Smart" CPAP Device to Treat Sleep Apnea 4China Wound Care Market 2China Wound Care Market 3
... SAN) and (NYSE: SNY)] announced today it has commenced a ... Genzyme Corporation (Nasdaq: GENZ ) for $69 per ... less any required withholding taxes.  The transaction is valued at ... sanofi-aventis, Board of Directors, is scheduled to expire at 11:59 ...
... Nephros, Inc. (OTC Bulletin Board: NEPH ... products for therapeutic applications, infection control, and water purification, ... bridge financing agreement with Lambda Investors LLC and has ... its stockholders.  Wexford Capital LP is the managing member ...
Cached Medicine Technology:Sanofi-aventis Commences Tender Offer to Acquire All Outstanding Shares of Genzyme for $69 per Share in Cash 2Sanofi-aventis Commences Tender Offer to Acquire All Outstanding Shares of Genzyme for $69 per Share in Cash 3Sanofi-aventis Commences Tender Offer to Acquire All Outstanding Shares of Genzyme for $69 per Share in Cash 4Sanofi-aventis Commences Tender Offer to Acquire All Outstanding Shares of Genzyme for $69 per Share in Cash 5Sanofi-aventis Commences Tender Offer to Acquire All Outstanding Shares of Genzyme for $69 per Share in Cash 6Sanofi-aventis Commences Tender Offer to Acquire All Outstanding Shares of Genzyme for $69 per Share in Cash 7Nephros Completes Bridge Financing and Announces Stockholder Rights Offering 2Nephros Completes Bridge Financing and Announces Stockholder Rights Offering 3Nephros Completes Bridge Financing and Announces Stockholder Rights Offering 4
Stryker autoclavable pediatric laparoscopes provide equivalent brightness and resolution along with the unparalleled durability found in larger laparoscopes....
The flexible nature of the vinyl allows the user to reach deeper into the chamber and allows for a greater comfort when working inside the glove box over a long period of time compared to any rigid s...
Bactron IV is designed for high volume, yet requires far less bench space than expected for its capacity and performance features....
Designed for larger laboratories or research applications, the Concept 1000 boasts some very unique features....
Medicine Products: